Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes.
Urien, Saik
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes. [electronic resource] - BMC pharmacology & toxicology Aug 2013 - 40 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article
2050-6511
10.1186/2050-6511-14-40 doi
Adolescent
Algorithms
Arthritis, Juvenile--drug therapy
C-Reactive Protein--metabolism
Child
Child, Preschool
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Hereditary Autoinflammatory Diseases--drug therapy
Humans
Infant
Injections, Subcutaneous
Interleukin 1 Receptor Antagonist Protein--pharmacokinetics
Male
Metabolic Clearance Rate
Models, Biological
Prospective Studies
Syndrome
Tissue Distribution
Treatment Outcome
Young Adult
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes. [electronic resource] - BMC pharmacology & toxicology Aug 2013 - 40 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article
2050-6511
10.1186/2050-6511-14-40 doi
Adolescent
Algorithms
Arthritis, Juvenile--drug therapy
C-Reactive Protein--metabolism
Child
Child, Preschool
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Hereditary Autoinflammatory Diseases--drug therapy
Humans
Infant
Injections, Subcutaneous
Interleukin 1 Receptor Antagonist Protein--pharmacokinetics
Male
Metabolic Clearance Rate
Models, Biological
Prospective Studies
Syndrome
Tissue Distribution
Treatment Outcome
Young Adult